Approval · Notice of Compliance 28872 · 2022
LOLO: Notice of Compliance 28872
Issued September 1, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28872
- Date
- September 1, 2022
- Company
- AbbVie CorporationSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Merger/Buy-out
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LOLO | 02417456 | Marketed |
Medicinal ingredients
- ETHINYL ESTRADIOL 10 MCG per TAB
- NORETHINDRONE ACETATE 1 MG per TAB